Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
BMJ Open. 2019 Jun 28;9(6):e025776. doi: 10.1136/bmjopen-2018-025776.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease. Preventing deterioration of health status is therefore an important therapy goal. (Minimal) Clinically Important Differences ((M)CIDs) are used to interpret changes observed. It remains unclear whether (M)CIDs are similar for both deterioration and improvement in health status. This study investigates and compares these clinical thresholds for three widely-used questionnaires.
Data were retrospectively analysed from an inhouse 3-week pulmonary rehabilitation (PR) randomised controlled trial in the German Klinik Bad Reichenhall (study 1), and observational research in Dutch primary and secondary routine clinical practice (RCP) (study 2).
Patients with COPD aged ≥18 years (study 1) and aged ≥40 years (study 2) without respiratory comorbidities were included for analysis.
The COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ) and St George's Respiratory Questionnaire (SGRQ) were completed at baseline and at 3, 6 and 12 months. A Global Rating of Change scale was added at follow-up. Anchor-based and distribution-based methods were used to determine clinically relevant thresholds.
In total, 451 patients were included from PR and 207 from RCP. MCIDs for deterioration ranged from 1.30 to 4.21 (CAT), from 0.19 to 0.66 (CCQ), and from 2.75 to 7.53 (SGRQ). MCIDs for improvement ranged from -3.78 to -1.53 (CAT), from -0.50 to -0.19 (CCQ), and from -9.20 to -2.76 (SGRQ). Thresholds for moderate improvement versus deterioration ranged from -5.02 to -3.29 vs 3.89 to 8.14 (CAT), from -0.90 to -0.72 vs 0.42 to 1.23 (CCQ), and from -15.85 to -13.63 vs 7.46 to 9.30 (SGRQ).
MCID ranges for improvement and deterioration on the CAT, CCQ and SGRQ were somewhat similar. However, estimates for moderate and large change varied and were inconsistent. Thresholds differed between study settings.
Routine Inspiratory Muscle Training within COPD Rehabilitation trial: #DRKS00004609; MCID study: #UMCG201500447.
慢性阻塞性肺疾病(COPD)是一种进行性疾病。因此,预防健康状况恶化是一个重要的治疗目标。(最小)临床重要差异(MCID)用于解释观察到的变化。目前尚不清楚 MCID 对于健康状况的恶化和改善是否相似。本研究调查并比较了这三种广泛使用的问卷的临床阈值。
这项回顾性分析的数据来自德国 Klinik Bad Reichenhall 的一项为期 3 周的肺康复(PR)随机对照试验(研究 1)和荷兰初级和二级常规临床实践(RCP)的观察性研究(研究 2)。
研究 1 纳入了年龄≥18 岁(研究 1)和≥40 岁(研究 2)且无呼吸合并症的 COPD 患者,研究 2 纳入了年龄≥40 岁且无呼吸合并症的 COPD 患者,用于分析。
COPD 评估测试(CAT)、临床 COPD 问卷(CCQ)和圣乔治呼吸问卷(SGRQ)在基线和 3、6 和 12 个月时进行了评估。在随访时增加了一个总体变化评级量表。使用基于锚定和基于分布的方法来确定具有临床意义的阈值。
共纳入了来自 PR 的 451 名患者和来自 RCP 的 207 名患者。CAT 恶化的 MCID 范围为 1.30 至 4.21,CCQ 为 0.19 至 0.66,SGRQ 为 2.75 至 7.53。CAT 改善的 MCID 范围为-3.78 至-1.53,CCQ 为-0.50 至-0.19,SGRQ 为-9.20 至-2.76。中等到改善与恶化的阈值范围为 CAT 为-5.02 至-3.29 比 3.89 至 8.14,CCQ 为-0.90 至-0.72 比 0.42 至 1.23,SGRQ 为-15.85 至-13.63 比 7.46 至 9.30。
CAT、CCQ 和 SGRQ 上改善和恶化的 MCID 范围有些相似。然而,中度和大幅度变化的估计值存在差异且不一致。阈值在研究环境之间存在差异。
COPD 康复中的常规吸气肌训练试验:#DRKS00004609;MCID 研究:#UMCG201500447。